Table 2.
Approved molecularly targeted drugs for esophageal cancer.
| Drug | Target | Company | Indication |
|---|---|---|---|
| Trastuzumab | HER2 | Pfizer | EAC |
| Ramucirumab | VEGFR | Lilly | EAC |
| Pembrolizumab | PD-1 | Merck Sharp & Dohme | ESCC |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.